Pamela H.

Pamela H. has over 15 years of experience in finance and accounting roles. Pamela began their career in 2006 as a Staff Accountant at GlobalEnglish. In 2008, they moved to Elan as a Staff Accountant I/II. From 2012 to 2017, they were the Controller at Mateon Therapeutics. Pamela then worked as a Finance and Accounting Consultant at Principia Biopharma from 2017 to 2018. During the same time period, they were the Associate Director, Clinical and Manufacturing Accounting at Catalyst Biosciences, Financial Controller at QED Therapeutics, and Corporate Controller at BridgeBio. In 2020, they became the Sr. Director, FP&A at Eidos Therapeutics, and in 2021 they were the VP of Finance at Dascena. Pamela is currently the VP of Finance at ENDPOINT HEALTH.

Pamela H. attended San Francisco State University where they earned a B.S. in Business Administration in Accounting.